World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015
The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.
Abstract
These guidelines for the treatment of unipolar depressive disorders systematically review available evidence pertaining to the biological treatment of patients with major depression and produce a series of practice recommendations that are clinically and scientifically meaningful based on the available evidence. These guidelines are intended for use by all physicians assessing and treating patients with these conditions. The relevant data have been extracted primarily from various treatment guidelines and panels for depressive disorders, as well as from meta-analyses/reviews on the efficacy of antidepressant medications and other biological treatment interventions identified by a search of the MEDLINE database and Cochrane Library. The identified literature was evaluated with respect to the strength of evidence for its efficacy and was then categorized into five levels of evidence (CE A-F) and five levels of recommendation grades (RG 1-5). This second part of the WFSBP guidelines on depressive disorders covers the management of the maintenance phase treatment, and is primarily concerned with the biological treatment (including pharmacological and hormonal medications, electroconvulsive therapy and other brain stimulation treatments) of adults and also, albeit to a lesser extent, children, adolescents and older adults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Currently, pharmacological and non-pharmacological treatments are relatively well established as having at least moderate efficacy for the short-term treatment of acute major depression (Undurraga and Baldessarini, 2012; Baldessarini, 2013; Bauer et al., 2015).”
From Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials (2016) · cites this paper as Bauer et al., 2015
In the citing paper
“Two (10%) other CPGs stated that withdrawal symptoms and relapse should be differentiated from each other when discontinuing antidepressants, but without considering the potential overlap of symptoms between these situations.3,44”
From Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review (2022) · cites this paper as [44]
In the citing paper
“only about 40% of all individuals and 49% of individuals with depressive disorders underwent electroconvulsive therapy, one of the most effective treatment options for major depressive disorder.38”
From “Nothing Hurts Less Than Being Dead”: Psychological Pain in Case Descriptions of Psychiatric Euthanasia and Assisted Suicide from the Netherlands: « Rien ne fait moins mal qu’être mort »: La douleur psychologique dans les descriptions de cas d’euthanasie et de suicide assisté psychiatrique aux Pays-Bas (2020) · cites this paper as [38]
In the citing paper
“Clinical guidelines recommend an additional 4 to 9 months of antidepressant treatment after initial response is achieved and at least 3 years of continual treatment for maintenance therapy, especially in patients who experience recurrent MDD (APA, 2010; Bauer et al., 2015).”
From Relapse prevention with levomilnacipran ER in adults with major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study (2019) · cites this paper as Bauer et al., 2015
Citations
Cites
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 1×
“A recurrence is a new episode that appears during recovery (i.e., sustained remission for XYZ days/weeks or longer following the most recent acute episode) (Frank et al. 1991; Kupfer 1993).”
BackgroundAgency for Health Care Policy and Research
Eisenberg, J. M. (1999) · Medical Care · doi:10.1097/00005650-199903000-00001 · Cited by 1,369
Three-Year Outcomes for Maintenance Therapies in Recurrent Depression
Frank, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240013002 · Cited by 1,297 · cited 2×
“A subsequent additional 2-year placebocontrolled study of the patients who completed the 3-year study (Frank et al. 1990) showed that imipramine (average dose of 200 mg/day) was signifi - cantly better than placebo in preventing recurrence (Kupfer et al. 1992).”
BackgroundChange in mental health after smoking cessation: systematic review and meta-analysis
Taylor, G., McNeill, A., Girling, A., Farley, A., Lindson-Hawley, N., & Aveyard, P. (2014) · BMJ · doi:10.1136/bmj.g1151 · Cited by 1,039 · cited 1×
“Smoking cessation has latterly been shown to reduce depression risk (Taylor et al. 2014).”
BackgroundDistributed Disturbances in Brain Structure and Function in Schizophrenia
(2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.1 · Cited by 969
Delivering interventions for depression by using the internet: randomised controlled trial
Christensen, H. (2004) · BMJ · doi:10.1136/bmj.37945.566632.ee · Cited by 928 · cited 1×
“Internet based approaches are increasingly being utilized (Christensen et al. 2004).”
MethodLithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013) · BMJ · doi:10.1136/bmj.f3646 · Cited by 920 · cited 1×
“A systematic review concluded that lithium is effective in the prevention of suicide, deliberate self-harm, and death from all causes in patients with mood disorders (Cipriani et al. 2013).”
BackgroundAnderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908 · cited 2×
“…al. 2012; Schaffer et al. 2012), the British Association for Psychopharmacology guidelines for treating depressive disorders with antidepressants (Anderson et al. 2008), the Australian and New Zealand clinical practice guidelines for the treatment of depression (Ellis 2004), the NICE guidelines…”
BackgroundRecurrence after recovery from major depressive disorder during 15 years of observational follow-up
Mueller, T. I., Leon, A. C., Keller, M. B., Solomon, D. A., Endicott, J., Coryell, W., Warshaw, M., & Maser, J. D. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1000 · Cited by 897 · cited 1×
“Fifty to 85% of the patients who have a major depressive episode will have another episode (Mueller et al. 1999; American Psychiatric Association 2000; Andrews 2001).”
BackgroundLithium toxicity profile: a systematic review and meta-analysis
McKnight, R. F., Adida, M., Budge, K., Stockton, S., Goodwin, G. M., & Geddes, J. R. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61516-x · Cited by 877 · cited 1×
“Among the well-established side effects of lithium treatment are reduced glomerular fi ltration rate, reduced urinary concentrating ability, hypothyroidism, hyperparathyroidism and weight gain (McKnight et al. 2012).”
Background
Research works printed but not linked: 27
- American Psychiatric Association, 2000, Am J Psychiatry, 157, 1
- Anderson IM, 2000, J Psychopharmacol, 14, 3, 10.1177/026988110001400101 · DOI · Paper page
- Angst J, 1999, J Clin Psychiatry, 60, 5
- Beaulieu S, 2012, Ann Clin Psychiatry, 24, 38
- Bond DJ, 2012, Ann Clin Psychiatry, 24, 23
- Burgess S, 2001, Cochrane Database Syst Rev, CD003013
- Cipriani A, 2006, Cochrane Database Syst Rev, CD003492
- Coppen A, 2000, J Clin Psychiatry, 61, 52
- Cox GR, 2012, Cochrane Database Syst Rev, 11, D007504
- Kupfer DJ, 1993, J Clin Psychiatry, 54, 29
- Lejoyeux M, 1997, J Clin Psychiatry, 58, 11
- McIntyre RS, 2012, Ann Clin Psychiatry, 24, 69
- McIntyre RS, 2012, Ann Clin Psychiatry, 24, 2
- Mohr DC, 2012, J Am Med Assoc, 307, 2278
- Montgomery SA, 1999, J Clin Psychiatry, 60, 10
- Mosolov SN, 1997, Zh Nevrol Psikhiatr Im S S Korsakova, 97, 30
- Pacchiarotti I, 2013, Am J Psychiatry
- Placidi GF, 1986, J Clin Psychiatry, 47, 490
- Ramasubbu R, 2012, Ann Clin Psychiatry, 24, 82
- Ramasubbu R, 2012, Ann Clin Psychiatry, 24, 91
- Rosenbluth M, 2012, Ann Clin Psychiatry, 24, 56
- Rush AJ, 1999, J Clin Psychiatry, 60, 21
- Schaffer A, 2012, Ann Clin Psychiatry, 24, 6
- Taylor MJ, 2013, Cochrane Database Syst Rev, 5, CD003382
- Thase ME, 1999, J Clin Psychiatry, 60, 3
- Tint A, 2008, J Psychopharmacol, 22, 330, 10.1177/0269881107081550 · doi:10.1177/0269881107081550 · Paper page
- Wilkinson P, 2012, Cochrane Database Syst Rev, 11, D006727
Cited by
Marx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00454-1 · Cited by 768
“Different guidelines make specific recommendations regarding first-line and second-line treatments for MDD and maintenance treatment across age groups and special populations 149,168,169 .”
Fedgchin, M., Trivedi, M., Daly, E. J., Melkote, R., Lane, R., Lim, P., Vitagliano, D., Blier, P., Fava, M., Liebowitz, M., et al. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz039 · Cited by 606
Exercise can improve sleep quality: A systematic review and meta-analysis
Banno, M., Harada, Y., Taniguchi, M., Tobita, R., Tsujimoto, H., Tsujimoto, Y., Kataoka, Y., & Noda, A. (2018) · PeerJ · doi:10.7717/peerj.5172 · Cited by 246
Sim, K., Lau, W. K., Sim, J., Sum, M. Y., & Baldessarini, R. J. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv076 · Cited by 218
Sforzini, L., Worrell, C., Kose, M., Anderson, I. M., Aouizerate, B., Arolt, V., Bauer, M., Baune, B. T., Blier, P., Cleare, A. J., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01381-x · Cited by 214
Self-citation
Metadata
- Authors
- Bauer, M., Severus, E., Köhler, S., Whybrow, P. C., Angst, J., Möller, H.-J., & on behalf of the Wfsbp Task Force on Treatment Guidelines for Unipolar Depressive Disorders
- Affiliations
- Technische Universität Dresden (DE)
- Charité – Universitätsmedizin Berlin (DE)
- University of California, Los Angeles (US)
- University of Zurich (CH)
- Ludwig-Maximilians-Universität München (DE)
- Corresponding author
- Bauer, Michael
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2015-02-13
- Volume
- 16
- Issue
- 2
- Pages
- 76-95
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2171166616
- Semantic Scholar
- 08abea4813fc2772a35482f1e6e14c9ffdcdc28f
- Cited by
- 199
- References
- 200
- Citations by year
- 2026: 10 · 2025: 7 · 2024: 19 · 2023: 15 · 2022: 26 · 2021: 18 · 2020: 25 · 2019: 22 · 2018: 20 · 2017: 24 · 2016: 8 · 2015: 5
- FWCI
- 13.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The World Journal of Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- GlaxoSmithKline
- Bundesministerium für Bildung und Forschung
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Keywords
- major depressive disorder, maintenance therapy, biological treatment, antidepressants, hormone therapy, electroconvulsive therapy, brain stimulation, children and adolescents, older adults, treatment guidelines
- MeSH terms
- Quetiapine Fumarate, Antidepressive Agents, Biological Psychiatry, Carbamazepine, Major Depressive Disorder, Dibenzothiazepines, Drug Therapy, Combination, Electroconvulsive Therapy, Humans, Lithium, Plant Extracts, Psychotherapy, Antipsychotic Agents, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015. https://app.cochat.ai/papers/10.3109/15622975.2014.1001786
- The paper
- Bauer, M., Severus, E., Köhler, S., Whybrow, P. C., Angst, J., Möller, H.-J., & on behalf of the Wfsbp Task Force on Treatment Guidelines for Unipolar Depressive Disorders. (2015). World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015. The World Journal of Biological Psychiatry. https://doi.org/10.3109/15622975.2014.1001786
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.